Search this website. You can use fund codes to locate specific funds

EOS

  • 23/09/2020
    Burberry case study
    Lisa Lange
    Burberry has reaffirmed its commitment to find alternatives to incinerating surplus stock in the midst of the coronavirus pandemic and set a science-based carbon reduction target.
  • 23/09/2020
    The coronavirus and the race for a vaccine
    Katie Frame
    With the coronavirus pandemic set to continue without an effective and widely-available vaccine, all eyes are on the pharmaceutical sector.
  • 10/09/2020
    Mizuho Financial Group case study
    Janet Wong
    Mizuho has made a commitment to ending financing of new coal-fired power plants and reducing exposure to coal-fired power plants to zero by 2050, the only Japanese bank to makes such a commitment.
  • 09/09/2020
    A voting season like no other
    Amy Wilson
    With many companies opting for virtual shareholder meetings, how did investors ensure their concerns about climate change, diversity and human rights risks were addressed?
  • 28/08/2020
    Antimicrobial resistance and the challenge for pharmaceutical companies
    Kimberley Lewis
    A lack of research and development into new antibiotic classes compounds the serious threat that antimicrobial resistance poses to public health.
  • 21/08/2020
    Repsol case study
    Andy Jones
    Repsol became the first oil and gas company to commit to a net-zero goal by 2050, supported by a decarbonisation pathway with interim targets, setting a higher benchmark for the industry. EOS has engaged with the company since 2013 on its climate action and targets.